307 related articles for article (PubMed ID: 7468137)
21. Management of postoperative heparin rebound following cardiopulmonary bypass.
Pifarré R; Babka R; Sullivan HJ; Montoya A; Bakhos M; El-Etr A
J Thorac Cardiovasc Surg; 1981 Mar; 81(3):378-81. PubMed ID: 7464201
[TBL] [Abstract][Full Text] [Related]
22. The effects of protamine overdose on coagulation parameters as measured by the thrombelastograph.
Khan NU; Wayne CK; Barker J; Strang T
Eur J Anaesthesiol; 2010 Jul; 27(7):624-7. PubMed ID: 20485179
[TBL] [Abstract][Full Text] [Related]
23. In vivo and in vitro evaluation of the heparin management test versus the activated coagulation time for monitoring anticoagulation level in aprotinin-treated patients during cardiac surgery.
Kim YS; Murkin JM; Adams SJ
Heart Surg Forum; 2004; 7(6):E599-604. PubMed ID: 15769695
[TBL] [Abstract][Full Text] [Related]
24. Automated protamine dose assay in heparin reversal management after cardiopulmonary by pass.
Guarracino F; De Cosmo D; Penzo D; Tedesco M; Bossi A; Zussa C; Polesel E; De Stefani R
Minerva Anestesiol; 2001 Apr; 67(4):165-9. PubMed ID: 11376504
[TBL] [Abstract][Full Text] [Related]
25. Heparin administration during extracorporeal circulation: heparin rebound and postoperative bleeding.
Kaul TK; Crow MJ; Rajah SM; Deverall PB; Watson DA
J Thorac Cardiovasc Surg; 1979 Jul; 78(1):95-102. PubMed ID: 449391
[TBL] [Abstract][Full Text] [Related]
26. Comparison of two protocols for heparin neutralization by protamine after cardiopulmonary bypass.
Arén C; Feddersen K; Rådegran K
J Thorac Cardiovasc Surg; 1987 Oct; 94(4):539-41. PubMed ID: 3309479
[TBL] [Abstract][Full Text] [Related]
27. More effective suppression of hemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACT.
Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Joiner-Maier D; Santoro SA; Spitznagel E; Weitz JI; Goodnough LT
Thromb Haemost; 1996 Dec; 76(6):902-8. PubMed ID: 8972009
[TBL] [Abstract][Full Text] [Related]
28. Kaolin-based activated coagulation time measured by sonoclot in patients undergoing cardiopulmonary bypass.
Ganter MT; Monn A; Tavakoli R; Klaghofer R; Zollinger A; Hofer CK
J Cardiothorac Vasc Anesth; 2007 Aug; 21(4):524-8. PubMed ID: 17678778
[TBL] [Abstract][Full Text] [Related]
29. Activated clotting time tests with heparinase in the management of pediatric patients on cardiopulmonary bypass.
Kriesmer P; Payne NR; Tessmer J; Uden DL
ASAIO J; 1993; 39(4):942-5. PubMed ID: 8123932
[TBL] [Abstract][Full Text] [Related]
30. [Routine heparinization and activated clotting time (ACT) in patients operated on under extracorporeal circulation].
Kalawski R; Krzyś T; Leciej M
Wiad Lek; 1982 Oct; 35(18):1119-24. PubMed ID: 7179984
[No Abstract] [Full Text] [Related]
31. Safety issues in heparin and protamine administration for extracorporeal circulation.
Jobes DR
J Cardiothorac Vasc Anesth; 1998 Apr; 12(2 Suppl 1):17-20. PubMed ID: 9583571
[TBL] [Abstract][Full Text] [Related]
32. [Our method and concept concerning the activated clotting time (ACT) during cardiopulmonary bypass].
Watanabe T; Abe T; Iyomasa Y
Kokyu To Junkan; 1983 Jul; 31(7):781-6. PubMed ID: 6658213
[No Abstract] [Full Text] [Related]
33. Heparin rebound phenomenon--much ado about nothing?
Martin P; Horkay F; Gupta NK; Gebitekin C; Walker DR
Blood Coagul Fibrinolysis; 1992 Apr; 3(2):187-91. PubMed ID: 1606290
[TBL] [Abstract][Full Text] [Related]
34. Heparin dose for accurate anticoagulation in cardiac surgery.
Doty DB; Knott HW; Hoyt JL; Koepke JA
J Cardiovasc Surg (Torino); 1979; 20(6):597-604. PubMed ID: 511928
[TBL] [Abstract][Full Text] [Related]
35. [Control of temporary anticoagulation in extracorporeal circulation using activated coagulation time].
Kessler G; Grünes G
Anaesthesist; 1984 Dec; 33(12):588-91. PubMed ID: 6528961
[TBL] [Abstract][Full Text] [Related]
36. [A clinical evaluation of the Hepcon/HMS: a new device of monitoring hemostasis management during cardiopulmonary bypass].
Yamanishi H; Watanabe S; Hayashi K; Tomioka H; Minami M; Nozaki Y; Aoki T; Kawai Y; Kishino K; Ohta S
Kyobu Geka; 1997 Jun; 50(6):459-62. PubMed ID: 9185440
[TBL] [Abstract][Full Text] [Related]
37. [How much dosage of heparin do you administer? The relationship between heparin dosage and activated coagulation time (ACT) value during cardiovascular surgery: a multi center investigations].
Shibasaki M; Nakajima Y; Kojima A; Kitagawa H; Tanimoto K; Mizobe T
Masui; 2010 Apr; 59(4):535-9. PubMed ID: 20420155
[TBL] [Abstract][Full Text] [Related]
38. An Adjusted Calculation Model Allows for Reduced Protamine Doses without Increasing Blood Loss in Cardiac Surgery.
Kjellberg G; Sartipy U; van der Linden J; Nissborg E; Lindvall G
Thorac Cardiovasc Surg; 2016 Sep; 64(6):487-93. PubMed ID: 26270199
[TBL] [Abstract][Full Text] [Related]
39. Heparin monitoring during cardiopulmonary bypass.
Saleem A; Shenaq SS; Yawn DH; Harshberger K; Diemunsch P; Mohindra P
Ann Clin Lab Sci; 1984; 14(6):474-9. PubMed ID: 6508227
[TBL] [Abstract][Full Text] [Related]
40. Hand-held personal digital assistant program for the HEMOCHRON RxDx heparin and protamine dosing system.
El Rouby S; Rinehart K; Zucker ML; LaDuca FM
J Extra Corpor Technol; 2003 Sep; 35(3):212-7. PubMed ID: 14653423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
